26 Jun 2019 --- Proprietary microbiome therapies company MicroSintesis has closed a minority investment deal worth Can$16.4 million (US$12.4 million) with Northern Private Capital (NPC), the investment vehicle of Clearwater Fine Foods Incorporated’s (CFFI) venture arm, CFFI Ventures. The funding will enable a scaled-up production of MicroSintesis’ existing products – probiotics for dogs and cats, as well as pigs and chickens.
